Free Trial

Universe Pharmaceuticals (UPC) Short Interest Ratio & Short Volume

$4.71 +0.22 (+4.90%)
As of 10/3/2025 03:57 PM Eastern

Universe Pharmaceuticals Short Interest Data

Universe Pharmaceuticals (UPC) has a short interest of 34,400 shares. This marks a 54.95% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 190,885 shares to cover all short positions.

Current Short Interest
34,400 shares
Previous Short Interest
22,200 shares
Change Vs. Previous Month
+54.95%
Dollar Volume Sold Short
$134.16 thousand
Short Interest Ratio
0.3 Days to Cover
Last Record Date
September 15, 2025
Outstanding Shares
560,000 shares
Percentage of Shares Shorted
6.14%
Today's Trading Volume
19,755 shares
Average Trading Volume
190,885 shares
Today's Volume Vs. Average
10%
Short Selling Universe Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Universe Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

UPC Short Interest Over Time

UPC Days to Cover Over Time

UPC Percentage of Float Shorted Over Time

Universe Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202534,400 shares $134.16 thousand +55.0%N/A0.3 $3.90
8/31/202522,200 shares $78.81 thousand -27.5%9.3%0.3 $3.55
8/15/202530,600 shares $107.71 thousand +25.4%N/A0.5 $3.52
7/31/202524,400 shares $86.38 thousand -19.5%10.2%0.3 $3.54
7/15/202530,300 shares $112.72 thousand -99.1%N/A0.1 $3.72
6/30/20253,370,000 shares $12.64 million +10,205.8%6.6%5.9 $3.75
6/15/202532,700 shares $130.15 thousand -20.6%181.7%0.1 $3.98
5/31/202541,200 shares $197.76 thousand -59.4%95.8%0.1 $4.80
5/15/2025101,400 shares $0.00 +35.6%235.8%0.3 $0.00

UPC Short Interest - Frequently Asked Questions

What is Universe Pharmaceuticals' current short interest?

Short interest is the volume of Universe Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 34,400 shares of UPC short. Learn More on Universe Pharmaceuticals' current short interest.

Is Universe Pharmaceuticals' short interest increasing or decreasing?

Universe Pharmaceuticals saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 34,400 shares, an increase of 55.0% from the previous total of 22,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Universe Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Universe Pharmaceuticals: Aptorum Group Limited (5.28%), AEON Biopharma, Inc. (1.15%), Biofrontera Inc. (1.59%), Matinas Biopharma Holdings, Inc. (3.63%), ESSA Pharma Inc. (2.85%), Addex Therapeutics Ltd. Sponsored ADR (5.61%), Avalon GloboCare Corp. (5.21%), IM Cannabis Corp. (0.38%), Kiora Pharmaceuticals, Inc. (0.22%), HCW Biologics Inc. (21.51%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

What does it mean to sell short Universe Pharmaceuticals stock?

Short selling UPC is an investing strategy that aims to generate trading profit from Universe Pharmaceuticals as its price is falling. UPC shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Universe Pharmaceuticals?

A short squeeze for Universe Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of UPC, which in turn drives the price of the stock up even further.

How often is Universe Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UPC, twice per month. The most recent reporting period available is September, 15 2025.




This page (NASDAQ:UPC) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners